BridgeBio Pharma, Inc. (BBIO)
71.12
+0.10
(+0.13%)
USD |
NASDAQ |
Mar 17, 15:04
BridgeBio Pharma EPS Diluted (Quarterly) : -0.9964 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Insmed, Inc. | -1.538 |
| Pfizer Inc. | -0.2898 |
| Mirum Pharmaceuticals, Inc. | -0.111 |
| Supernus Pharmaceuticals, Inc. | -0.0716 |
| Cogent Biosciences, Inc. | -0.6934 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -194.64M |
| Revenue (Quarterly) | 154.18M |
| Total Expenses (Quarterly) | 347.04M |
| Enterprise Value | 15.92B |
| Gross Profit Margin (Quarterly) | 94.27% |
| Profit Margin (Quarterly) | -126.2% |
| Earnings Yield | -5.32% |
| Normalized Earnings Yield | -5.203 |